These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5374927)

  • 1. On the absorption of prednisone and prednisolone disodium phosphate after rectal administration.
    Halvorsen S; Myren J; Aakvaag A
    Scand J Gastroenterol; 1969; 4(7):582-4. PubMed ID: 5374927
    [No Abstract]   [Full Text] [Related]  

  • 2. Betamethasone 17-valerate and prednisolone 21-phosphate retention enemata in proctocolitis. A multicentre trial.
    Br Med J; 1971 Jul; 3(5766):84-6. PubMed ID: 5090826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic benefits from a poorly absorbed prednisolone enema in distal colitis.
    McIntyre PB; Macrae FA; Berghouse L; English J; Lennard-Jones JE
    Gut; 1985 Aug; 26(8):822-4. PubMed ID: 3894171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of inflammatory bowel disease on absorption and disposition of prednisolone.
    Milsap RL; George DE; Szefler SJ; Murray KA; Lebenthal E; Jusko WJ
    Dig Dis Sci; 1983 Feb; 28(2):161-8. PubMed ID: 6825536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function.
    Frey BM; Walker C; Frey FJ; de Weck AL
    J Immunol; 1984 Nov; 133(5):2479-87. PubMed ID: 6237151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption of delayed-release prednisolone in ulcerative colitis and Crohn's disease.
    Thomas P; Richards D; Richards A; Rogers L; Evans BK; Dew MJ; Rhodes J
    J Pharm Pharmacol; 1985 Oct; 37(10):757-8. PubMed ID: 2867153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisolone.
    Schalm SW; Summerskill WH; Go VL
    Gastroenterology; 1977 May; 72(5 Pt 1):910-3. PubMed ID: 849821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. URINARY EXCRETION OF PREDNISOLONE AFTER INTRARECTAL THERAPY IN ULCERATIVE COLITIS.
    WOOD WA; WALTERS G; FLAVELLMATTS SG
    Br Med J; 1964 Oct; 2(5416):1045-6. PubMed ID: 14191165
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biotransformation of prednisone to prednisolone in patients with liver cirrhosis].
    Madsbad S; Bjerregaard B; Henriksen JH; Juhl E; Kehlet H
    Ugeskr Laeger; 1979 May; 141(20):1325-8. PubMed ID: 452141
    [No Abstract]   [Full Text] [Related]  

  • 10. Prednisolone clearance: a possible determinant for glucocorticoid efficacy in patients with oral vesiculo-erosive diseases.
    Lozada F; Frey FJ; Benet LZ
    J Dent Res; 1983 May; 62(5):575-7. PubMed ID: 6573375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability and reversible metabolism of prednisone and prednisolone in man.
    Garg V; Jusko WJ
    Biopharm Drug Dispos; 1994 Mar; 15(2):163-72. PubMed ID: 8011967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative bioavailability of prednisone and prednisolone in man.
    Tse FL; Welling PG
    J Pharm Pharmacol; 1979 Jul; 31(7):492-3. PubMed ID: 38330
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical pharmacokinetics of prednisone and prednisolone.
    Pickup ME
    Clin Pharmacokinet; 1979; 4(2):111-28. PubMed ID: 378499
    [No Abstract]   [Full Text] [Related]  

  • 14. Prednisone and prednisolone kinetic observations after liver transplantation.
    Townsend RJ; Albert KS; Gibson FM; Sakmar E; Wagner JG
    Clin Pharm; 1983; 2(2):103-4. PubMed ID: 6349903
    [No Abstract]   [Full Text] [Related]  

  • 15. Impaired conversion of prednisone to prednisolone in patients with liver cirrhosis.
    Madsbad S; Bjerregaard B; Henriksen JH; Juhl E; Kehlet H
    Gut; 1980 Jan; 21(1):52-6. PubMed ID: 7364321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of complex formation on drug absorption. XII. Enhancement of intestinal absorption of prednisone and prednisolone by dialkylpropionamides in rats.
    Hayton WL; Levy G
    J Pharm Sci; 1972 Mar; 61(3):362-6. PubMed ID: 5013369
    [No Abstract]   [Full Text] [Related]  

  • 17. [Systemic availability of prednisolone following oral administration of prednisone].
    Frey BM; Brandenberger AW; Frey FJ; Widmer HR
    Pharm Acta Helv; 1984; 59(11):301-9. PubMed ID: 6514760
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies comparing the metabolic clearance rate of 11 beta,17,21-trihydroxypregn-1,4-diene-3,20-dione (prednisolone) after oral 17,21-dihydroxypregn-1,4-diene-3,11,20-trione and intravenous prednisolone.
    Hsueh WA; Paz-Guevara A; Bledsoe T
    J Clin Endocrinol Metab; 1979 May; 48(5):748-52. PubMed ID: 429520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible metabolism and pharmacokinetics: application to prednisone-prednisolone.
    Wagner JG; DiSanto AR; Gillespie WR; Albert KS
    Res Commun Chem Pathol Pharmacol; 1981 Jun; 32(3):387-405. PubMed ID: 7268190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral prednisolone-21-phosphate is absorbed at the same rate and to the same extent as oral prednisolone in normal adults.
    Olivesi A
    Therapie; 1985; 40(1):1-4. PubMed ID: 4002177
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.